Cargando…

Pre-existing Helicobacter pylori serum IgG enhances the vibriocidal antibody response to CVD 103-HgR live oral cholera vaccine in Malian adults

Accumulating evidence indicates that persistent Helicobacter pylori gastric infection influences immune responses to oral enteric vaccines. We studied the association between pre-existing H. pylori serum IgG and serum pepsinogens levels (PGs) as markers of gastric inflammation and the immune respons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muhsen, Khitam, Sow, Samba O., Tapia, Milagritos D., Haidara, Fadima C., Reymann, Mardi, Asato, Valeria, Chen, Wilbur H., Pasetti, Marcela F., Levine, Myron M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547695/ https://www.ncbi.nlm.nih.gov/pubmed/33037244 http://dx.doi.org/10.1038/s41598-020-71754-9

Ejemplares similares

Age-Dependent Association among Helicobacter pylori Infection, Serum Pepsinogen Levels and Immune Response of Children to Live Oral Cholera Vaccine CVD 103-HgR
por: Muhsen, Khitam, et al.
Publicado: (2014)

Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial Comparing the Reactogenicity and Immunogenicity of a Single Standard Dose to Those of a High Dose of CVD 103-HgR Live Attenuated Oral Cholera Vaccine, with Shanchol Inactivated Oral Vaccine as an Open-Label Immunologic Comparator
por: Sow, Samba O., et al.
Publicado: (2017)

CVD 103-HgR live, attenuated cholera vaccine strain viability in drinking waters from the US and Europe
por: Duffin, R. Paul, et al.
Publicado: (2021)

Safety and Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Children and Adolescents Aged 6–17 Years
por: McCarty, James M., et al.
Publicado: (2020)

Safety and Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Children Aged 2–5 Years in the United States
por: McCarty, James M., et al.
Publicado: (2021)

Long-Term Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Adolescents Aged 12–17 Years in the United States
por: McCarty, James M., et al.
Publicado: (2021)

Evaluation of a Booster Dose of Pentavalent Rotavirus Vaccine Coadministered With Measles, Yellow Fever, and Meningitis A Vaccines in 9-Month-Old Malian Infants
por: Haidara, Fadima C, et al.
Publicado: (2018)

A Phase 3, Double-Blind, Randomized, Active Controlled Study to Evaluate the Safety of MenAfriVac in Healthy Malians
por: Tapia, Milagritos D., et al.
Publicado: (2015)

Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children
por: Sow, Samba O., et al.
Publicado: (2023)

Respiratory Syncytial Virus (RSV) Neutralizing Antibodies at Birth Predict Protection from RSV Illness in Infants in the First 3 Months of Life
por: Buchwald, Andrea G, et al.
Publicado: (2020)

Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers
por: Islam, Kamrul, et al.
Publicado: (2018)

Vibriocidal Titer and Protection From Cholera in Children
por: Ritter, Alaina S, et al.
Publicado: (2019)

Maternal Influenza Vaccination and the Risk of Laboratory-Confirmed Influenza Among Household Contacts Under the Age of Five in Mali
por: Buchwald, Andrea G., et al.
Publicado: (2019)

Clinical Evaluations Have Low Sensitivity for Identifying Preterm Infants in a Clinical Trial in a Limited Resource Setting
por: Buchwald, Andrea G., et al.
Publicado: (2019)

Measles susceptibility in maternal-infant dyads—Bamako, Mali
por: Dixon, Meredith G., et al.
Publicado: (2022)

Epidemiology, Risk Factors, and Outcomes of Respiratory Syncytial Virus Infections in Newborns in Bamako, Mali
por: Buchwald, Andrea G, et al.
Publicado: (2020)

Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial
por: Tapia, Milagritos D, et al.
Publicado: (2016)

HGR-ViT: Hand Gesture Recognition with Vision Transformer
por: Tan, Chun Keat, et al.
Publicado: (2023)

A Systematic Review and Meta-analysis of the Association Between Giardia lamblia and Endemic Pediatric Diarrhea in Developing Countries
por: Muhsen, Khitam, et al.
Publicado: (2012)

Strategies for Coordination of a Serosurvey in Parallel with an Immunization Coverage Survey
por: Travassos, Mark A., et al.
Publicado: (2015)

Cost-effectiveness of maternal influenza immunization in Bamako, Mali: A decision analysis
por: Orenstein, Evan W., et al.
Publicado: (2017)

Different Plasmodium falciparum clearance times in two Malian villages following artesunate monotherapy
por: Kone, Aminatou, et al.
Publicado: (2020)

Chemical Composition and Mechanism of Vibriocidal Action of Essential Oil from Resin of Protium heptaphyllum
por: Mendes, Josiane Lima, et al.
Publicado: (2019)

Kinetics of maternally-derived serogroup A, C, Y and W-specific meningococcal immunoglobulin G in Malian women and infants
por: Findlow, H., et al.
Publicado: (2019)

In vivo validation of anti-malarial activity of crude extracts of Terminalia macroptera, a Malian medicinal plant
por: Haidara, Mahamane, et al.
Publicado: (2018)

Complexity of Plasmodium falciparum infection and genetic variations associated with differences in parasite clearance time in two Malian villages
por: Sissoko, Sekou, et al.
Publicado: (2023)

Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial
por: Tapia, Milagritos D, et al.
Publicado: (2016)

Immunization Coverage Surveys and Linked Biomarker Serosurveys in Three Regions in Ethiopia
por: Travassos, Mark A., et al.
Publicado: (2016)

1105. Vibriocidal Titer Variation and Likelihood of Protection in Children Compared With Adults in a Cholera Endemic Area
por: Ritter, Alaina, et al.
Publicado: (2018)

The HGR motif is the antiangiogenic determinant of vasoinhibin: implications for a therapeutic orally active oligopeptide
por: Robles, Juan Pablo, et al.
Publicado: (2021)

An unusual case of Dyke–Davidoff–Masson syndrome revealed by status epilepticus in a Malian patient
por: Djimdé, Samba O., et al.
Publicado: (2022)

Background Rates of Adverse Pregnancy Outcomes for Assessing the Safety of Maternal Vaccine Trials in Sub-Saharan Africa
por: Orenstein, Lauren A. V., et al.
Publicado: (2012)

Combined Clinical Audits and Low-Dose, High-frequency, In-service Training of Health Care Providers and Community Health Workers to Improve Maternal and Newborn Health in Mali: Protocol for a Pragmatic Cluster Randomized Trial
por: Zombre, David, et al.
Publicado: (2021)

Vibriocidal activity of certain medicinal plants used in Indian folklore medicine by tribals of Mahakoshal region of central India
por: Sharma, Anjana, et al.
Publicado: (2009)

IgM specific to lipopolysaccharide of Vibrio cholerae is a surrogate antibody isotype responsible for serum vibriocidal activity
por: Yang, Jae Seung, et al.
Publicado: (2019)

The Global Enteric Multicenter Study (GEMS): Impetus, Rationale, and Genesis
por: Levine, Myron M., et al.
Publicado: (2012)

Enhanced Humoral Immune Responses against Toxin A and B of Clostridium difficile is Associated with a Milder Disease Manifestation
por: Na’amnih, Wasef, et al.
Publicado: (2020)

Diabetes in an emergency context: the Malian case study
por: Besançon, Stéphane, et al.
Publicado: (2015)

Descriptive study of cases of schizophrenia in the Malian population
por: Coulibaly, Souleymane dit Papa, et al.
Publicado: (2021)

Importancia perinatal del estudio de la placenta en H.G.R. no.36
por: Cortés Vásquez, F. Jose Luis
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_2o6fb26234hjbb0ul3m4pmtt4a